Found: 8
Select item for more details and to access through your institution.
Virus‐Induced Host Chemokine CCL2 in COVID‐19 Pathogenesis: Potential Prognostic Marker and Target of Anti‐Inflammatory Strategy.
- Published in:
- Reviews in Medical Virology, 2024, v. 34, n. 5, p. 1, doi. 10.1002/rmv.2578
- By:
- Publication type:
- Article
Upregulation of interleukin-19 in saliva of patients with COVID-19.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-20087-w
- By:
- Publication type:
- Article
Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals.
- Published in:
- International Immunology, 2006, v. 18, n. 10, p. 1443, doi. 10.1093/intimm/dxl078
- By:
- Publication type:
- Article
IL-17 Induced Autophagy Regulates Mitochondrial Dysfunction and Fibrosis in Severe Asthmatic Bronchial Fibroblasts.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01002
- By:
- Publication type:
- Article
Systems Immunology Analysis Reveals an Immunomodulatory Effect of Snail-p53 Binding on Neutrophil- and T Cell-Mediated Immunity in KRAS Mutant Non-Small Cell Lung Cancer.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.569671
- By:
- Publication type:
- Article
Azithromycin Differentially Alters TCR-Activated Helper T Cell Subset Phenotype and Effector Function.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.556579
- By:
- Publication type:
- Article
Interleukin-17, a salivary biomarker for COVID-19 severity.
- Published in:
- PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0274841
- By:
- Publication type:
- Article
Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1447625
- By:
- Publication type:
- Article